University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Ryutaro Hirose, MD

Ryutaro Hirose, MD

Assistant Professor, Department of Surgery, UCSF

Selected Publications

  1. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes. Hepatology. 2018 Dec 13.
    View on PubMed
  2. Bertsimas D, Kung J, Trichakis N, Wang Y, Hirose R, Vagefi PA. Development and validation of an Optimized Prediction of Mortality for candidates awaiting liver transplantation. Am J Transplant. 2018 Nov 09.
    View on PubMed
  3. Cooper M, Formica R, Friedewald J, Hirose R, O'Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clin Transplant. 2018 Oct 21; e13419.
    View on PubMed
  4. Cullaro G, Hirose R, Lai JC. Changes in Simultaneous Liver Kidney Transplant Allocation Policy May Impact Post Liver Transplant Outcomes. Transplantation. 2018 Aug 06.
    View on PubMed
  5. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation. Liver Transpl. 2018 Aug 01.
    View on PubMed
  6. Patel MS, Hirose R, Vagefi PA. How Good Is Good? Benchmarking and the Quest for Quality Improvement in Liver Transplantation. Ann Surg. 2018 Mar; 267(3):426-427.
    View on PubMed
  7. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11).
    View on PubMed
  8. Hirose R, Heimbach J. Defining disparities in liver transplantation: The devil is in the details. Liver Transpl. 2017 04; 23(4):557-558.
    View on PubMed
  9. Deshpande R, Hirose R, Mulligan D. Liver allocation and distribution: time for a change. Curr Opin Organ Transplant. 2017 Apr; 22(2):162-168.
    View on PubMed
  10. Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation. 2016 10; 100(10):2153-9.
    View on PubMed
  11. Gentry SE, Hirose R, Mulligan D. Resolving Misconceptions About Liver Allocation and Redistricting Methodology. JAMA Surg. 2016 10 01; 151(10):991-992.
    View on PubMed
  12. Parekh J, Roll GR, Wisel S, Rushakoff RJ, Hirose R. Effect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation. Clin Transplant. 2016 10; 30(10):1242-1249.
    View on PubMed
  13. Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? J Surg Oncol. 2016 Oct; 114(5):587-596.
    View on PubMed
  14. Edwards EB, Harper AM, Hirose R, Mulligan DC. The impact of broader regional sharing of livers: 2-year results of "Share 35". Liver Transpl. 2016 Apr; 22(4):399-409.
    View on PubMed
  15. Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy? Gastroenterology. 2016 Feb; 150(2):533-4.
    View on PubMed
  16. Olmos A, Feiner J, Hirose R, Swain S, Blasi A, Roberts JP, Niemann CU. Impact of a quality improvement project on deceased organ donor management. Prog Transplant. 2015 Dec; 25(4):351-60.
    View on PubMed
  17. Gentry SE, Segev DL, Kasiske BL, Mulligan DC, Hirose R. Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity. Transplantation. 2015 Sep; 99(9):e159-60.
    View on PubMed
  18. Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, Broglio K, Hirose R, Roberts JP, Malinoski D. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med. 2015 Jul 30; 373(5):405-14.
    View on PubMed
  19. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  20. Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, Olthoff KM, Harper A, Snyder JJ, Israni AK, Kasiske BL, Kim WR. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology. 2015 May; 61(5):1643-50.
    View on PubMed

Go to UCSF Profiles, powered by CTSI